Effect of Levonorgestrel Intrauterine System on Hemoglobin Level

Assiut University

Status: Not yet enrolling

Conditions: Hemoglobin; Deficiency

Treatments: Device: Levonorgestrel intrautrine system

Study type: Interventional

Funder types: Other

Identifiers

NCT06935968

Mirena

Details and patient eligibility

About

To study the effect of LNG-IUS on improving iron status in reproductive-aged women presenting for contraception.

Full description

Women come to family planning clinic to insert levonorgestrel intrautrine system and take a blood sample from her to analyse hemoglobin level

Enrollment: 100 estimated patients

Sex: Female

Ages: 18 to 45 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

1. The study will include married women attending the outpatient clinics of the forementioned health facilities for contraception counseling
2. Age between 18 and 45 years
3. Women who choose LNG_IUS for contraception
4. Any parity including nulliparous

Exclusion criteria

• 1.Women with any inherited hemoglobinopathy (thalassemia, sickle cell anemia) or acquired hemolytic anemia 2.Women with sever iron deficiency anemia requiring immediate treatment 3.Women with any contraindication to Mirena insertion (pelvic inflammatory disease, cervical or vaginal infection, cervical cancer) 4. Any uterine abnormality making LNG_IUS insertion difficult (septate uterus or fibroid distorting the cavity) 5. Women within 6 months of delivery

Trial design

Primary purpose: Health Services Research

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

100 participants in 1 patient group

Levonorgestrel intrauterine system insertion

Other group

Treatment:

Device: Levonorgestrel intrautrine system